BAX 855 PK-guided Dosing

NCT02585960 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
135
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Baxalta now part of Shire

Collaborators